Industry-leading iPSC Gene Editing Technology
Get the highest precision and efficiency with Ncardia’s proprietary STAR-CRISPR technology
STAR-CRISPR far surpasses other established gene editing methodologies.
Partner with Ncardia to:
- Reduce unintended edits in oncogenes and coding regions
- Mitigate safety risks in iPSC genetic modifications
- Access knock-out efficiency of ~90%, surpassing Cas9 and MAD7
- Utilize knock-in efficiency up to 50%, 2-3 times higher than other methods
Power Your Research With STAR-CRISPR Technology
What to Expect From Ncardia iPSC Gene Editing Service

Unmatched Efficiency
and minimal off-targets

Streamlined Experience
With Ncardia's proprietary technology

Quick Turnaround
Get your iPSC line edited in 12-16 weeks
How Does STAR-CRISPR Measure Up?
CRISPR-based systems have two key components:
- Guide RNA (gRNA) — a short RNA sequence matching the target DNA sequence to be edited
- DNA cutting enzyme — typically Cas9 or their derivatives
Among all the CRISPR-based systems available to edit iPSCs, STAR-CRISPR stands out with:
Unparalleled efficiencies in gene knock-in and knock-out
Minimal off-target editing



Explore Related Services
Let's start a conversation
about your needs
As more and more drug innovators look to capitalize on the unique value only iPSCs can deliver, they look to Ncardia as their qualified collaborator to join them.
